Innospec 대차대조표 건전성
재무 건전성 기준 점검 6/6
Innospec 의 총 주주 지분은 $1.4B 이고 총 부채는 $0.0, 이는 부채 대 자기자본 비율을 0% 로 가져옵니다. 총자산과 총부채는 각각 $1.8B 및 $467.6M 입니다. Innospec 의 EBIT는 $144.7M 이며 이자보상배율은 -19 입니다. $289.1M 의 현금 및 단기 투자금을 보유하고 있습니다.
핵심 정보
0%
부채/자본 비율
US$0
부채
| 이자보상배율 | -19x |
| 현금 | US$289.10m |
| 자본 | US$1.35b |
| 총부채 | US$467.60m |
| 총자산 | US$1.82b |
최근 재무 건전성 업데이트
Recent updates
IOSP: Higher Revenue Outlook And Stable Fair Value Will Support Future Upside
Analysts have adjusted their price target for Innospec to $99.33. This reflects updated views on the company's discount rate, revenue growth assumptions, profit margin outlook and future P/E expectations.IOSP: Stable Margins And Lower Discount Rate Will Support Future Upside
Analysts have maintained their price target for Innospec at $99.33, citing only marginal tweaks to inputs such as discount rate, revenue growth, profit margin and future P/E assumptions rather than any change in their overall view of the shares. Valuation Changes Fair Value: Model fair value remains unchanged at $99.33 per share.IOSP: Refined Discount Rate And Stable Margins Will Support Upside Potential
Analysts have set their price target for Innospec at $99.33. The updated view reflects modest adjustments to the discount rate, long-run revenue growth, profit margin and future P/E assumptions, while the fair value estimate remains $99.33.IOSP: Stable Assumptions And Lower Discount Rate Will Support Rebound Upside Potential
Analysts have nudged their price target for Innospec slightly lower to about $99.33, reflecting small refinements to their discount rate, projected revenue growth, profit margin and future P/E assumptions rather than a major shift in the story. Valuation Changes Fair Value: Model estimate is unchanged at about $99.33 per share.Innospec: Oilfield Services Bound For A Recovery
Summary Innospec is positioned as a likely beneficiary of energy shortages and rising oil prices, supplying vital chemicals for oil extraction and refining. IOSP trades at a 50% discount to sector P/E and EV/EBITDA multiples, despite a debt-free balance sheet and strong free cash flow generation. Operational catalysts include potential recovery in oilfield services, resolution of the Mexico crisis, and increased demand from geopolitical disruptions. I rate IOSP a strong buy due to its discounted valuation, share repurchase support, and expected oilfield recovery. Read the full article on Seeking AlphaIOSP: Higher Assumed P/E Will Support Rebound Upside Potential
Narrative Update The updated analyst price target for Innospec is now $99.33. Analysts point to adjusted assumptions for discount rate, revenue growth, profit margin, and future P/E as the key drivers behind this revised view.IOSP: Steady Assumptions Will Support Rebound Upside Potential
Analysts maintained their Innospec fair value estimate at approximately $99, making only minor adjustments to the discount rate, revenue growth, profit margin, and future P/E assumptions that support their price targets. Valuation Changes Fair Value: Kept steady at around $99 per share, with no change in the underlying estimate.IOSP: New Product And Opportunistic M&A Upside To Support Rebound
Analysts have adjusted their price target on Innospec to US$93, citing the stock's recent underperformance, what they describe as bottoming earnings, and potential upside from new product offerings or opportunistic M&A as key reasons for the change. Analyst Commentary Bullish Takeaways Bullish analysts view the new US$93 target as reflecting what they see as a discount to the company’s value as a specialty chemicals maker, given its product mix and market positions.Estimating The Fair Value Of Innospec Inc. (NASDAQ:IOSP)
Key Insights Innospec's estimated fair value is US$76.10 based on 2 Stage Free Cash Flow to Equity Innospec's US$83.50...IOSP: New Offerings And Opportunistic M&A Will Drive Future Upside Potential
Analysts have raised their price target on Innospec to US$93, stating that they view the stock as undervalued with potential upside from new product offerings or opportunistic M&A as earnings stabilize. Analyst Commentary Bullish Takeaways Bullish analysts view Innospec as undervalued relative to its current earnings profile, which they see as not fully reflecting potential contributions from new products or deals.IOSP: New Offerings And Opportunistic M&A Will Support Future Upside
Analysts have raised their price target on Innospec to about US$99. This change is supported by views that the company remains undervalued, with potential upside from new product offerings or opportunistic M&A, and an earnings profile that they believe has begun to bottom.IOSP: Share Repurchases And Dividend Increases Will Drive Future Upside
Analysts have modestly raised their price target on Innospec to approximately $99 per share from about $93, citing the stock's recent underperformance, bottoming earnings, and potential upside from new products or opportunistic M&A as supporting reasons for a more favorable risk reward outlook. Analyst Commentary Recent commentary from bullish analysts underscores a constructive stance on Innospec, emphasizing a favorable balance between current valuation and prospective growth drivers.IOSP: Share Repurchase And Dividend Will Drive Upside From Recent Lows
Analysts have lowered Innospec's fair value estimate from $107.50 to $99.33 per share, citing recent stock underperformance and the view that, although potential growth from new offerings or acquisitions exists, near-term challenges temper risk-reward expectations. Analyst Commentary Recent commentary from market observers provides a nuanced view of Innospec's near-term and long-term prospects.IOSP: Share Repurchase And Dividend Moves Will Sustain Bullish Momentum
Analysts have reaffirmed Innospec’s fair value estimate at $107.50 per share. They cite stable market conditions and modest improvements in profitability as factors supporting their unchanged outlook.IOSP: Continued Share Buybacks And Expanding Partnerships Will Support Future Upside
Analysts have maintained their price target for Innospec at $107.50, reflecting stability in their outlook as modest adjustments to discount rates and minor refinements in growth and margin forecasts were incorporated into their valuation models. What's in the News Performance Chemicals business enters its second year of partnership with International Justice Mission.Sustainable Chemicals And Battery Chemistry Will Open Future Markets
Analysts have lowered their fair value estimate for Innospec from $115 to $107.50. They cite tempered expectations for revenue growth and profit margins as the reason for this adjustment.Innospec Inc.'s (NASDAQ:IOSP) Popularity With Investors Is Under Threat From Overpricing
It's not a stretch to say that Innospec Inc.'s ( NASDAQ:IOSP ) price-to-sales (or "P/S") ratio of 1.1x right now seems...Innospec Inc. (NASDAQ:IOSP) Shares Could Be 33% Above Their Intrinsic Value Estimate
Key Insights Innospec's estimated fair value is US$59.10 based on 2 Stage Free Cash Flow to Equity Innospec's US$78.60...Innospec (NASDAQ:IOSP) Will Want To Turn Around Its Return Trends
NasdaqGS:IOSP 1 Year Share Price vs Fair Value Explore Innospec's Fair Values from the Community and select yours...Innospec Inc. (NASDAQ:IOSP) Investors Are Less Pessimistic Than Expected
There wouldn't be many who think Innospec Inc.'s ( NASDAQ:IOSP ) price-to-sales (or "P/S") ratio of 1.2x is worth a...Innospec (NASDAQ:IOSP) Is Increasing Its Dividend To $0.84
Innospec Inc.'s ( NASDAQ:IOSP ) dividend will be increasing from last year's payment of the same period to $0.84 on...Should You Think About Buying Innospec Inc. (NASDAQ:IOSP) Now?
Innospec Inc. ( NASDAQ:IOSP ), might not be a large cap stock, but it saw a double-digit share price rise of over 10...Innospec Inc.'s (NASDAQ:IOSP) Intrinsic Value Is Potentially 26% Below Its Share Price
Key Insights Using the 2 Stage Free Cash Flow to Equity, Innospec fair value estimate is US$70.78 Current share price...Innospec Well-Placed To Navigate Uncertain Times
Summary Innospec generated solid Q4 results relative to comparable specialty chemical companies, including strong volume growth in Fuel Specialties and Performance Chemicals and healthy margins. The outlook for 2025 is shakier, but diesel fuel demand should remain positive and further high-grading of the Performance Chemicals portfolio can offset some risk of weaker consumer spending. Oilfield is a harder call, given the company's exposure to more volatile trends in Latin America and the frac market. Despite a challenging macroeconomic environment, I remain bullish on Innospec's long-term prospects, driven by underlying volume growth drivers in Fuel Specialties and Performance Chemicals and opportunities to build the portfolio. Innospec's shares look undervalued, with discounted cash flow and EV/EBITDA pointing to a double-digit long-term annualized return and a target price of $120. Read the full article on Seeking AlphaInnospec Inc. (NASDAQ:IOSP) Not Flying Under The Radar
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 18x, you may...Returns At Innospec (NASDAQ:IOSP) Appear To Be Weighed Down
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'd...Is Now An Opportune Moment To Examine Innospec Inc. (NASDAQ:IOSP)?
While Innospec Inc. ( NASDAQ:IOSP ) might not have the largest market cap around , it saw significant share price...Do Innospec's (NASDAQ:IOSP) Earnings Warrant Your Attention?
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...Innospec (NASDAQ:IOSP) Will Pay A Larger Dividend Than Last Year At $0.79
Innospec Inc. ( NASDAQ:IOSP ) has announced that it will be increasing its dividend from last year's comparable payment...Innospec Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Shareholders of Innospec Inc. ( NASDAQ:IOSP ) will be pleased this week, given that the stock price is up 11% to US$120...Pinning Down Innospec Inc.'s (NASDAQ:IOSP) P/E Is Difficult Right Now
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 18x, you may...Returns On Capital At Innospec (NASDAQ:IOSP) Have Stalled
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'll want to see a proven...At US$110, Is Innospec Inc. (NASDAQ:IOSP) Worth Looking At Closely?
While Innospec Inc. ( NASDAQ:IOSP ) might not have the largest market cap around , it saw significant share price...Fuel Specialties And Performance Chemicals Propel Robust Financial Growth
Innospec's strategic acquisitions and innovation in Performance Chemicals and Fuel Specialties suggest sustained growth and improved profitability.Innospec Navigating Turbulent End-Markets And Specialty Chemical De-Rating Relatively Well
Summary Despite outperforming many larger rivals, Innospec's stock has seen volatility, including recent weakness that was likely driven by very weak Oilfield Services revenue. Innospec's Q2 showed strength in Fuel Specialties and Performance Chemicals but was dragged down by significant weaknesses in Oilfield Services. Innospec's diverse markets offer growth opportunities but also face macroeconomic uncertainties. Innospec's focus on "better for you" personal care chemicals is a key differentiator. Innospec continues to leverage M&A, like its acquisition of QGP Quimica, to enhance its growth prospects, and I expect additional deals to add targeted product/market exposure. While near-term macro challenges persist, Innospec's disciplined R&D approach and focus on high-margin products position it for long-term growth with potential high single-digit to low double-digit returns. Read the full article on Seeking AlphaEstimating The Intrinsic Value Of Innospec Inc. (NASDAQ:IOSP)
Key Insights The projected fair value for Innospec is US$115 based on 2 Stage Free Cash Flow to Equity With US$131...Returns On Capital At Innospec (NASDAQ:IOSP) Have Hit The Brakes
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...With EPS Growth And More, Innospec (NASDAQ:IOSP) Makes An Interesting Case
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...Innospec (NASDAQ:IOSP) Is Increasing Its Dividend To $0.76
Innospec Inc. ( NASDAQ:IOSP ) has announced that it will be increasing its dividend from last year's comparable payment...Innospec Inc.'s (NASDAQ:IOSP) Share Price Could Signal Some Risk
Innospec Inc.'s ( NASDAQ:IOSP ) price-to-earnings (or "P/E") ratio of 22.3x might make it look like a sell right now...Innospec (NASDAQ:IOSP) Has More To Do To Multiply In Value Going Forward
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...Is Innospec Inc. (NASDAQ:IOSP) Potentially Undervalued?
Innospec Inc. ( NASDAQ:IOSP ), might not be a large cap stock, but it saw a decent share price growth of 13% on the...Estimating The Fair Value Of Innospec Inc. (NASDAQ:IOSP)
Key Insights Innospec's estimated fair value is US$134 based on 2 Stage Free Cash Flow to Equity Current share price of...Here's Why We Think Innospec (NASDAQ:IOSP) Might Deserve Your Attention Today
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...재무 상태 분석
단기부채: IOSP 의 단기 자산 ( $999.1M )이 단기 부채( $334.8M ).
장기 부채: IOSP의 단기 자산($999.1M)이 장기 부채($132.8M)를 초과합니다.
부채/자본 비율 추이 및 분석
부채 수준: IOSP 부채가 없습니다.
부채 감소: IOSP는 5년 전에 부채가 없었습니다.
부채 범위: IOSP 은 부채가 없으므로 영업현금흐름으로 충당할 필요가 없습니다.
이자 보장: IOSP 에는 부채가 없으므로 이자 지불에 대한 보장은 문제가 되지 않습니다.
대차대조표
건전한 기업 찾아보기
기업 분석 및 재무 데이터 상태
| 데이터 | 최종 업데이트 (UTC 시간) |
|---|---|
| 기업 분석 | 2026/05/13 23:00 |
| 종가 | 2026/05/13 00:00 |
| 수익 | 2026/03/31 |
| 연간 수익 | 2025/12/31 |
데이터 소스
당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.
| 패키지 | 데이터 | 기간 | 미국 소스 예시 * |
|---|---|---|---|
| 기업 재무제표 | 10년 |
| |
| 분석가 컨센서스 추정치 | +3년 |
|
|
| 시장 가격 | 30년 |
| |
| 지분 구조 | 10년 |
| |
| 경영진 | 10년 |
| |
| 주요 개발 | 10년 |
|
* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.
별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.
분석 모델 및 스노우플레이크
이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.
Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.
산업 및 섹터 지표
산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.
분석가 소스
Innospec Inc.는 7명의 분석가가 다루고 있습니다. 이 중 3명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
| 분석가 | 기관 |
|---|---|
| Jonathan Tanwanteng | CJS Securities, Inc. |
| David Silver | Freedom Capital Markets |
| Sean Milligan | Johnson Rice & Company, L.L.C. |